Next-generation drug from Eli Lilly boosts weight loss to 24% ... - CNN
2023年6月26日 · An experimental drug from Eli Lilly helped patients with obesity lose an average of 24% of their body weight over 48 weeks on the highest dose in a mid-stage study, the most weight loss seen...
What You Need to Know About New Weight Loss Drugs
2024年10月21日 · Are Ozempic, Wegovy and other approved drugs safe and effective for older adults? Here's what to know about new weight loss drugs
New Oral Weight Loss Drugs: Where Are We and What's Next? - Medscape
2024年6月5日 · Now that semaglutide (Wegovy), tirzepatide (Zepbound), and other injectables have created an insatiable market for weight loss drugs, biotech and pharmaceutical companies are roaring...
The Race for the Next Ozempic - WIRED
2024年7月24日 · Hot on the heels of semaglutide is Eli Lilly’s tirzepatide, approved as Mounjaro in 2022 for diabetes and as Zepbound in 2023 for weight management. In studies of Zepbound, patients taking the...
16 New Weight Loss Drugs - GoodRx
2024年10月1日 · Several new weight-loss drugs are making waves in clinical trials. This includes pills such as oral semaglutide, orforglipron, and amycretin. The same goes for injectable medications, such as retatrutide, CagriSema (cagrilintide and semaglutide), and MariTide (maridebart cafraglutide).
FDA Approves New Drug Treatment for Chronic Weight …
Today, the U.S. Food and Drug Administration approved Wegovy (semaglutide) injection (2.4 mg once weekly) for chronic weight management in adults with obesity or overweight with at least one...
FDA approves Eli Lilly’s Zepbound, a weight loss drug similar to ...
2023年11月8日 · The Food and Drug Administration on Wednesday approved Zepbound, a new weight loss drug from drugmaker Eli Lilly that was shown in clinical trials to help people lose up to 52 pounds in 16...
What to know about Zepbound, Eli Lilly’s new weight loss drug - NBC News
2023年11月9日 · Zepbound belongs to a new class of medications, alongside Ozempic and Wegovy, that have skyrocketed in popularity in the U.S. A new weight loss drug has been approved that promises to be the most...
Weight loss drug Zepbound is now available, Eli Lilly says
2023年12月6日 · Drug manufacturer Eli Lilly announced Tuesday that its flagship weight loss medication, Zepbound, is now available for patient use. Tirzepatide, its active ingredient, had been approved by...
What to Know About Zepbound, the New Weight Loss Drug - The New York Times
2023年11月8日 · The decision by the Food and Drug Administration on Wednesday to approve the weight loss drug tirzepatide adds a potent new tool to the fast-growing arsenal of obesity drugs. The drug, which...
- 某些结果已被删除